Mary Kathryn(Duncan)MalecekMD

PubMed

• 14 citations
  Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma
  Victor M. Orellana-Noia, Krista Isaac, Mary-Kate Malecek, Nancy L. Bartlett, Timothy J Voorhees
  Blood Advances. 2021-09-28
• 54 citations
  Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.
  Victor M. Orellana-Noia, Daniel R Reed, A. Mccook, Jeremy M Sen, Christian M Barlow
  Blood. 2021-09-27
• 26 citations
  Early Relapse Identifies MCL patients with Inferior Survival after Intensive or Less Intensive Frontline Therapy.
  David A. Bond, Jeffrey M. Switchenko, Diego Villa, Kami J. Maddocks, Michael C. Churnetski
  Blood Advances. 2021-09-13

Abstracts/Posters

• Maintenance Rituximab Improves Outcomes in Mantle Cell Lymphoma Patients Who Respond to Induction Therapy with Bendamustine + Rituximab without Autologous Transplant
  Mary-Kate Malecek, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Clinical Trial Participation Is Associated with Improved Overall Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma
  Mary-Kate Malecek, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Fitness and Anthracycline Use in Front-Line Therapy for Older Patients with Classical Hodgkin Lymphoma: A US Multi-Center Retrospective Analysis
  Mary-Kate Malecek, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Outcomes Following Early Relapse in Patients with Mantle Cell Lymphoma
  Mary-Kate Malecek, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• North American Practice Patterns for PET-2 Positive Hodgkin Lymphoma
  Mary-Kate Malecek, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all